Bigul

CAPLIN POINT LABORATORIES LTD. - 524742 - Corporate Action-Board approves Dividend

The Board had approved interim dividend for the year ended 31-03-2024. The details of the same is enclosed herewith
16-05-2024
Bigul

CAPLIN POINT LABORATORIES LTD. - 524742 - Results For The Quarter And Year Ended March 31, 2024

The results for the quarter and year ended March 31, 2024 along with the details of interim divided is attached herewith
16-05-2024
Bigul

CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Outcome for Financial Results Outcome

Financial Results for the quarter and year ended March 31, 2024 is enclosed
16-05-2024
Bigul

CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Intimation for Financial Results And Declaration Of Interim Dividend, If Approved By The Board.

CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 ,inter alia, to consider and approve Annual audited financial results of the Company for the year ended March 31, 2024 (both standalone & consolidated) and declaration of Interim Dividend, if any, for the FY 2023-24 and fixation of record date for determining the eligibility of shareholders.
09-05-2024
Bigul

CAPLIN POINT LABORATORIES LTD. - 524742 - General Announcements

Please find the attached Press Release on Grant of INVIMA Approval
06-05-2024
Bigul

CAPLIN POINT LABORATORIES LTD. - 524742 - Compliance Certificate In Terms Of Regulation 40 (10) Of The SEBI Listing Regulations

The Compliance Certificate issued by PCS for the year ended March 31, 2024 is attached herewith
25-04-2024
Bigul

Caplin Point: What should investors do

Steady expansion in products and markets to play out in next two years
20-04-2024
Next Page
Close

Let's Open Free Demat Account